MYOS Corporation Stock News

NEW YORK, NY / ACCESSWIRE / July 8, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following mergers are fair to shareholders. Halper Sadeh LLP may se

Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers ar

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of MYOS RENS Technology Inc. ("MYOS" or the "Company") (NASDAQ: MYOS) in connect

NEW YORK, NY / ACCESSWIRE / July 7, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek incre

MYOS RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a biotherapeutics and bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition derived from fertiliz

NEW YORK, NY / ACCESSWIRE / July 6, 2020 / The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholder

NEW YORK, NY / ACCESSWIRE / July 3, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP m

BALA CYNWYD, PA / ACCESSWIRE / July 2, 2020 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of MYOS RENS Technology Inc. ("MYOS

New York, New York--(Newsfile Corp. - July 2, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased MYOS RENS Technology Inc. (NASDAQ: MYO

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.36%

Stocks are a mixed bag at midday to kick off July, with the Dow giving back an earlier lead while the S&P 500 and Nasdaq hang on to marginal gains

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.30%

MYOS RENS Technology, Inc. ("MYOS") (NASDAQ: MYOS), an advanced nutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, and MedAvail, Inc. (

MYOS RENS Technology Inc. ("MYOS") (NASDAQ: MYOS), a bionutrition company and the owner of Fortetropin®, a proprietary bioactive composition that helps build lean muscle, announced today that it will